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Abstract
Objective: The purpose of this work was to compare measured and estimated volumetry prior to liver
resection.
Methods: Data for consecutive patients submitted to major liver resection for colorectal liver metas-
tases at two centres during 2004–2012 were reviewed. All patients underwent volumetric analysis to
define the measured total liver volume (mTLV) and measured future liver remnant ratio (mRFLR). The
estimated total liver volume (eTLV) standardized to body surface area and estimated future liver rem-
nant ratio (eRFLR) were calculated. Descriptive statistics were generated and compared. A difference
between mRFLR and eRFLR of 5% was considered clinically relevant.
Results: Data for a total of 116 patients were included. All patients underwent major resection and
51% underwent portal vein embolization. The mean difference between mTLV and eTLV was 157 ml
(P < 0.0001), whereas the mean difference between mRFLR and eRFLR was 1.7% (P = 0.013). By lin-
ear regression, eTLV was only moderately predictive of mTLV (R2 = 0.35). The distribution of differ-
ences between mRFLR and eRFLR demonstrated that the formula over- or underestimated mRFLR by
≥5% in 31.9% of patients.
Conclusions: Measured and estimated volumetry yielded differences in the FLR of ≥5% in almost
one-third of patients, potentially affecting clinical decision making. Estimated volumetry should be used
cautiously and cannot be recommended for general use.
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Introduction
Major hepatectomy is commonly used in the treatment of pri-
mary and secondary liver malignancies. Following major hepa-
tectomy, liver insufficiency or ‘small-for-size syndrome’ is
associated with significant morbidity and mortality.1
Liver insufficiency is a clinical syndrome whereby the rem-
nant liver fails to sustain adequate organ function, leading to
hyperbilirubinaemia, coagulopathy, ascites, encephalopathy and
hypoalbuminaemia. It may lead to further renal and/or respira-
tory failure, infectious complications, and ultimately to postop-
erative death.1,2 Despite this general understanding of the
syndrome, it remains ill defined, as evidenced by the varying
interchangeable terminology utilized in the literature. It has
been referred to as liver ‘insufficiency’, ‘failure’ and ‘dysfunc-
tion’, as well as ‘small-for-size syndrome’. At least four groups
have attempted to define this syndrome based on various clini-
cal parameters, in two instances utilizing postoperative death
from liver failure as an objective outcome.3–6
Despite varying definitions, there is consensus in the litera-
ture regarding the importance of maintaining adequate rem-
nant volume following liver resection. Although other factors
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are thought to influence post-resection liver function, such as
the health of the remaining parenchyma, age, diabetes,
chemotherapy-associated injury, operative blood loss and
cholestasis,2 most authors agree that a minimal future liver
remnant (FLR) exists for safe resection. In a young and other-
wise healthy patient with normal underlying liver parenchyma,
commonly reported FLR cut-off values typically represent
20–30% of the patient’s total liver volume (TLV).4,7–9
Several techniques exist to measure the FLR. Most centres
measure liver volumes directly on cross-sectional imaging and
compute the remnant to TLV ratio using only functional non-
tumoral liver as representative of TLV. Alternatively, another
technique has been described by Vauthey’s group and is often
used in practice.10 It consists of estimating the TLV based on a
patient’s body surface area (BSA), measuring the future liver
volume on cross-sectional imaging, and then calculating the
percentage of the FLR that can now be considered to be stan-
dardized to the patient’s BSA. Given that these two techniques
are inherently different, the objective of this work was to deter-
mine the accuracy and variability of each volumetric method
in the context of major hepatic resection.
Materials and methods
Patients
A retrospective review of the medical records of consecutive
patients submitted to major liver resection at two major ter-
tiary hepatobiliary units in Canada and the Netherlands,
respectively, during 2004–2012 was carried out. Approval for
this study was sought and obtained from the Ethics Committee
of the Centre de Recherche du Centre Hospitalier de l’Univer-
site de Montreal (CR-CHUM 12.221). In the Netherlands,
research ethics approval was waived for this type of study by
the Academic Medical Centre Ethics Board.
Patient selection criteria were defined a priori, before any
data acquisition or analysis. Inclusion criteria required that: (i)
the patient had undergone major liver resection (three or more
segments)6 for metastatic colorectal cancer, and (ii) the patient
had undergone volumetric analysis to determine the volume of
his or her FLR. Exclusion criteria ruled out data for: (i)
patients for whom volumetric data measured prior to any liver
surgery or intervention [e.g. staged resection or portal vein
embolization (PVE)] were not available; (ii) patients for whom
data on height and weight were not available, and (iii) patients
with chronic liver disease. These criteria were chosen to define
a homogeneous study population in which volumetric analysis
would not be affected by hepatic remodelling from prior liver
interventions, chronic liver disease, or biliary tract dilation. All
patients were thus pre-PVE or pre-staged resection, if neces-
sary, and were thus expected to yield a comparison of volu-
metric assessment techniques that was as objective as possible.
At the Canadian centre, all measurements were recorded within
a prospective database for clinical utilization. At the Dutch
centre, measurements included both prospectively recorded
volumes and some retrospective volumes generated from the
original pre-intervention imaging. At both centres, volumetry
was utilized commonly for major hepatectomy at the surgeon’s
discretion.
Data on patient and tumour characteristics included details
of age, gender, weight, height, number of liver lesions, and
pathological changes within the peritumoral liver parenchyma.
Treatment characteristics recorded included details of neoadju-
vant chemotherapy, type of major liver resection, and require-
ment for PVE.
Liver volume measurements
At the Canadian centre, all volumetric analyses were performed
by one trained radiology technician (AB) during the entire dura-
tion of the study. Senior liver surgeons verified all measurements
and utilized the data for clinical practice (FV-M, RL, MD). A
dedicated GE Advantage Workstation 4.2 (GE Healthcare, Inc.,
Waukesha, WI, USA) was used for this work. For each patient,
relevant volumes were measured using portal phase computed
tomography (CT) or magnetic resonance imaging (MRI) of the
liver. When both CT and MRI scans were available, the CT scan
was used preferentially. Measured total liver volume (mTLV)
was obtained by delineating the liver contour manually on every
cut with slice thickness of 5 mm or every one or two cuts with
slice thickness of ≤3 mm. Volume was calculated by the software
based on the total surface area measured on each imaging cut
and the distance between slices. Total tumour volume (TV) and
FLR volume were measured in a similar fashion. The caudate
lobe was always included in volume measurements. Couinaud
segmental anatomy was defined in the usual fashion on the basis
of portal vein and hepatic vein anatomy.11 Intrahepatic portal
pedicles and hepatic veins were included within the tracings. The
gallbladder, extrahepatic portal pedicles, extrahepatic hepatic
veins and inferior vena cava were excluded from volume mea-
surements according to the accepted method of segmenting the
liver.10
At the Dutch centre, all volumetric analyses were performed
by one surgical trainee experienced in performing volumetric
measurements (KPC) and verified by an experienced radiolo-
gist (KPvL). Integrated software (Mx-View 3.52; Philips Medi-
cal Systems BV, Best, the Netherlands) was used to calculate all
liver volumes. All relevant volumes were measured using portal
phase CT scans with 5-mm slice thickness. Total volume, FLR
volume and mTLV were measured using the same technique as
at the Canadian centre.
Volumetric analysis
For each patient, relevant liver volumes were measured ‘manu-
ally’ using the technique outlined above (mTLV, TV and FLR
volume). From these data, the measured FLR ratio (mRFLR),
expressed as the predicted percentage of liver remaining after
resection, was calculated as: mRFLR = (FLR volume/mTLV 
TV) 9 100.
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In parallel, each patient’s estimated FLR ratio (eRFLR) was
also calculated using the technique described by Vauthey
et al.10 Using this method, the patient’s BSA is calculated12
and then used to estimate the TLV (eTLV) as follows:
eTLV = 794.41 + 1267.28 9 BSA. From these data, the
eRFLR can be calculated as: eRFLR = (FLR volume/eTLV).
1
Using this technique, only the FLR volume is measured on
cross-sectional imaging. It should also be noted that TV is not
incorporated in this formula.
Statistical analysis
Summary statistics were generated for each study centre and
for the entire cohort. Continuous variables were reported as
means and standard deviations (SDs) or medians as appropri-
ate. Dichotomous and categorical variables were reported as
proportions. Data from the two study centres were compared
using unpaired t-tests or Wilcoxon tests for continuous vari-
ables, as appropriate, and chi-squared or Fisher’s tests for
dichotomous variables. Different techniques for liver volumet-
ric measurements were compared for the same cohorts of
patients using paired t-tests. Measured and estimated TLV and
FLR ratios were also compared using Spearman correlations.
Finally, simple linear regression was carried out to determine
the goodness of fit in models with measured values as inde-
pendent variables and estimated values as dependent variables.
R2 values were derived, indicating the proportion of the
response-variable variation that is explained by the linear
model.
In order to determine the clinical relevance of computed dif-
ferences between volumetric measurement techniques, a mini-
mal difference of 5% in the predicted FLR ratios was
defined. Because estimated volumetry was originally derived
from manual measurements,10 the latter was considered to rep-
resent the reference standard for the purpose of this study.
Both measured and estimated volumetric data were thus gener-
ated, and the proportion of patients in whom mRFLR and
eRFLR differed by ≥5% was calculated. For this comparison,
binomial proportions and Ward 95% confidence intervals
(CIs) were generated.
All statistical analyses were carried out using SAS Version 9.2
(SAS Institute, Inc., Cary, NC, USA).
Results
Patients
A total of 116 patients were included in this study, of whom
73 were treated at the Canadian centre and 43 at the Dutch
centre (Table 1). The study cohort was homogeneous, except
for significant differences in median height (170 cm versus
175 cm; P = 0.0058) and body mass index (BMI) (26.4 kg/m2
versus 24.5 kg/m2; P = 0.029), reported pathological changes
in the peritumoral liver parenchyma (22.7% versus 51.2%;
P = 0.0022), and utilization of PVE (61.6% versus 32.6%;
P = 0.0025).
Total liver volumes
Data for TLV in the whole cohort are shown in Table 2. There
was no significant difference in TLV data between the two
study centres, whether measured or estimated (data not
shown). A mean difference of 157 ml (P < 0.0001) was identi-
fied in a comparison of mTLV and eTLV across the whole
cohort. The total range of paired differences was wide and
included both positive and negative differences (485 ml to
1693 ml), indicating that eTLV may be either greater or smal-
ler than mTLV (Fig. 1). The mean  SD differences for the
two study centres did not differ significantly (112  297 ml
versus 235  484 ml; P = 0.14). Spearman’s correlation
between mTLV and eTLV was 0.652 (P < 0.0001). Simple
linear regression gave an R2 value of 0.350.
In 29 patients (25.0%), the differences between mTLV and
eTLV were >1 SD from the mean (≥380 ml); 82.8% of these
patients were male. Measured livers in 27 (93.1%) of these 29
patients were larger than would have been predicted based on
BSA, and 24 of the 27 patients demonstrated livers of
>2000 ml in volume. A comparison of patients with and with-
out a difference of >1 SD between mTLV and eTLV showed
no significant difference in BMI (≥30 kg/m2: 17.2% versus
16.1%; P = 0.88), BSA (1.96 m2 versus 1.90 m2; P = 0.21) or
weight (80 kg versus 77 kg; P = 0.47). However, there was a
significant difference in mean height (1.75 m versus 1.70 m;
P = 0.015).
Table 1 Patient characteristics in 116 patients submitted to major
liver resection for colorectal liver metastases
Characteristic
Age, years, mean  SD (range) 59.7  11.0 (30–80)
Gender, male, n (%) 76 (65.5%)
Height, cm, median (range) 170 (147–192)
Weight, kg, median (range) 76.0 (47–160)
BMI, kg/m2, median (range) 25.8 (15.2–52.8)
Neoadjuvant chemotherapy, yes, n (%) 46 (48.9%) (n = 94)
Neoadjuvant cycles –
Peritumoral parenchyma, n (%) Abnormal: 37/109 (33.9%)
Cholestasis, 4
SOS, 10
Steatosis, 23
Fibrosis, 3
Steatohepatitis, 1
Number of liver lesions, median (range) 2.0 (1–15)
Liver resection type, n (%)
Three or four segments 72 (62.6%) (n = 115)
Five or six segments 43 (37.4%) (n = 115)
PVE, yes, n (%) 59 (50.9%)
BMI, body mass index; PVE, portal vein embolization; SD, standard
deviation; SOS, sinusoidal occlusive syndrome.
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Future liver remnant ratios
Future liver remnant data for the whole cohort are shown in
Table 2. There was no significant difference in FLR measure-
ments between the two study centres, whether measured or
estimated (data not shown). A mean difference of 1.7%
(P = 0.013) was identified when comparing mRFLR and eRFLR.
The total range of paired differences was wide and ranged from
negative to positive values (39.8% to 14.2%), indicating that
eRFLR could be either greater or smaller than mRFLR (Fig. 2).
The mean difference did not differ significantly between the
two study centres (1.2  5.7% versus 2.5  9.4%;
P = 0.37). Spearman’s correlation between the two techniques
for FLR was 0.909 (P < 0.0001). Univariate linear regression
gave an R2 value of 0.797.
In total, 31.9% (95% CI 23.4–40.4%) of patients (n = 37)
were found to have a clinically significant paired difference
between mRFLR and eRFLR of ≥5% (Fig. 3). Among those, data
for 51.4% (n = 19) and 24.3% (n = 9) were found to show
differences that would be expected to alter preoperative deci-
sion making, assuming mRFLR decision thresholds of 40% and
30%, respectively. Among patients with differences of ≥5%,
70.3% (n = 26) had negative differences such that eRFLR over-
estimated mRFLR by ≥5%. In all cases of overestimation, the
predicted eTLV using the formula was smaller than that mea-
sured on imaging. In the remainder (29.7%, n = 11), eRFLR
underestimated mRFLR.
The effect of TV on these findings was evaluated by repeat-
ing the calculation, but with TV included within TLV (i.e.
Table 2 Total liver volume (TLV) and future liver remnant (FLR) ratio measurements and comparisons across the entire cohort (n = 116)
by technique
Item Mean  SD (range) Mean difference P-value
Measured volumetry (mTLV), ml 1787  471
(range: 1029–3409)
157.0 (95% CI 87.4–227.0)
(range: 485 to 1693)
<0.0001
Estimated volumetry (eTLV), ml 1630  283
(range: 1022–2730)
Measured volumetry (mRFLR) 36.7  13.2%
(range: 4.2–85.5%)
1.7% (95% CI 3.1% to 0.4%)
(range: 39.8% to 14.2%)
0.013
Estimated volumetry (eRFLR) 38.4  16.0%
(range: 2.8–84.3%)
95% CI, 95% confidence interval; eRFLR, estimated future liver remnant ratio; mRFLR, measured future liver remnant ratio.
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mRFLR = FLR volume/mTLV 9 100). The mean difference
between mRFLR and eRFLR was 3.5% (P < 0.0001). In this
scenario, 39.7% of patients (n = 46) had a paired difference
between mRFLR and eRFLR of ≥5%.
These calculations were repeated using five other published
formulae to estimate TLV.10,13–16 The findings were consistent
across formulae (data not shown), with all formulae yielding a
difference between mRFLR and eRFLR of ≥5% in 32–60% of
patients (Table 3).
Discussion
This work has examined the two techniques most commonly
used to determine the FLR ratio. Using measured volumetry as
the comparative standard, estimated volumetry has been shown
to lead to a clinically significant over- or underestimation of
the FLR ratio by ≥5% in 31.9% of patients undergoing major
liver resection for colorectal liver metastases.
The current findings are significant because differences in
preoperative estimations of the FLR ratio may lead to changes
in patient management. In the event of overestimation of the
FLR ratio, the surgeon may be misled into thinking that a
given patient has sufficient FLR to allow for major liver resec-
tion, which may potentially put the patient at risk for liver
insufficiency. By contrast, with underestimation, the surgeon
may prefer to induce further hypertrophy with potentially
unnecessary preoperative PVE, thus placing the patient at addi-
tional risk for the occurrence of complications and delaying
surgery. Both over- and underestimations of the FLR ratio may
lead to a modification of the surgical plan, including the
utilization of techniques to induce contralateral liver hypertrophy
such as PVE or ligation, the modification of the surgical resec-
tion plan, the utilization of parenchyma-sparing ablative tech-
niques, as well as the cancellation of surgery in the case of an
insufficient FLR ratio. In either direction, inaccurate estimation
of the FLR ratio can have significant implications for patient
care.
This work has considered measured volumetry to represent
the reference standard with which to compare estimated vol-
umetry because not only is it the most widely used method,
but Vauthey et al.’s original description utilized measured vol-
umetric data from four centres to generate a linear regression
equation, from which TLV can be estimated based on BSA.10
In this context, the present results are not surprising as the
original linear regression equation yielded an R2 value of 0.46,
indicating that Vauthey et al.’s regression model10 can explain
only 46% of the variability in mTLV. Thus, there remains
much variability in predicting a given patient’s TLV, which
cannot simply be estimated based on BSA. Similar results were
obtained in the current study, in which the R2 for TLV was
only 0.35, such that the eTLV explains only 35% of the vari-
ability in mTLV. Moreover, it is important to note that the
current work excluded any patients with chronic liver disease
or any patient who may have had prior liver surgery. In those
patients, pre-existing parenchymal remodelling is expected and
it is likely that estimations of TLV based on BSA would be
much less accurate. Indeed, a patient’s eTLV based on BSA is
expected to remain constant over time (except with significant
weight variations), whereas it is fair to say that TLV is a
dynamic value that may change based on the health of the liver
and any prior interventions. Thus, a measurement of the TLV
that reflects its current state rather than a theoretical constant
value is likely to be superior.
Numerous factors can influence the accuracy of preoperative
liver volumetry that relies upon measured tracings. These
include the phase of contrast administration, cross-section slice
thickness, the use of CT versus MRI, varying hardware com-
puter platforms, varying image processing or radiological soft-
ware, and inter-user variability, as well as the degree to which
non-parenchymal structures (e.g. intrahepatic bile ducts or
tumours) are erroneously included within the functional liver
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Figure 3 Distribution of paired differences in the future liver
remnant (FLR) between measurement techniques
Table 3 Absolute differences of ≥5% in paired comparisons of
future liver remnant ratio based on different techniques (whole
cohort, n = 116)
Comparison Absolute difference
≥5% a
n % 95% CI
Measured/BSA Vauthey et al. (2002)10 37 31.9% 23.4–40.4
Measured/weight Vauthey et al. (2002)10 45 38.8% 29.9–47.7
Measured/BSA Heinemann et al. (1999)15 41 35.3% 26.7–44.0
Measured/BSA Deland et al. (1968)13 41 35.3% 26.7–44.0
Measured/BSA Urata et al. (1995)14 70 60.3% 51.4–69.3
Measured/age and weight Sinai et al.
(2001)16
55 47.4% 38.3–56.5
a
Binomial proportions for one-way tables, asymptotic (Ward) confi-
dence limits.
95% CI, 95% confidence interval; BSA, body surface area.
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volume.17 In the present work, significant efforts were made to
standardize the measurement techniques across the two study
sites. The study group chose to remain pragmatic with respect
to imaging phase selection, slice thickness and MRI use. The
present authors argue that observed differences in measured
and estimated volumetry are unlikely to relate to differences in
tracing methodology because the general technique used was
the same as that employed in the original derivation study.10
Tumour volume was excluded from measurements, which, in
fact, appears to render the present estimate more conservative.
Ribero et al.18 also examined this question. They reviewed
242 patients without cirrhosis who underwent major hepatec-
tomy for metastatic and primary liver tumours. They found a
small difference between measured and estimated TLV of
92 ml (P < 0.001), and noted that this difference became more
pronounced in patients with a BMI of >30 kg/m2.18 This
group also reported that the proportions of patients in whom
FLR was found to be inadequate on measured and estimated
volumetry, respectively, differed significantly (19.3% versus
30.0%; P = 0.006).18 In the current paper, estimated volumetry
was more frequently associated with an underestimation of the
eTLV and a resulting overestimation of the eRFLR. By contrast,
Ribero et al.18 reported the opposite pattern, whereby esti-
mated volumetry was more frequently associated with overesti-
mation of the eTLV and underestimation of the eRFLR.
Although this difference would appear surprising, the present
authors argue that it simply reflects inherent differences in the
distribution of patients in each study. As Fig. 3 shows, paired
differences between mTLV and eTLV and between mRFLR and
eRFLR are normally distributed, which allows for both the over-
and underestimation of the TLV and FLR ratio in any given
individual patient.
Examination of the patterns of difference between mTLV and
eTLV suggests that there exists a subgroup of patients in whom
estimated volumetry performs poorly. This was particularly evi-
dent in a subgroup of patients with livers that were significantly
larger than might have been expected based on their body habi-
tus. Although these patients were generally taller than the
remainder of the cohort, this discrepancy remains incompletely
explained at present and will require further investigation.
According to a review by Johnson et al.,19 at least 12 groups
have reported different formulae for estimating TLV based on
various parameters such as age, gender, weight, height and
BSA. All formulae were derived from different patient popula-
tions, some of which focused on specific ethnicities such as
‘Japanese’, ‘North American’ or ‘North European’. This abun-
dance of formulae aimed at estimating the same parameter
would suggest that no single formula relying on traditional
morphologic values is likely to successfully account for the full
range of variability observed in TLV. Lim et al.17 also argued
this point, demonstrating that, in an average 60-kg adult
patient, estimations of TLV derived from the various formulae
available would range from 1024 ml to 1302 ml. This could
result in an FLR ratio of 23–29%, assuming a measured rem-
nant of 300 ml. These results are comparable with those of the
present study. Clearly, for liver volumetry to be useful to sur-
geons, it must be more consistently accurate and reliable. This
notion also underscores the need for quantitative liver function
tests in the assessment of the FLR in patients requiring major
liver resection.20 The findings of this study would suggest that
TLV is best evaluated by direct radiologic measurement rather
than by indirect estimation if a more accurate assessment of
the FLR ratio is to be generated.
The limitations of the current study include its retrospective
nature and moderate sample size. In addition, this work did
not examine the functional consequences of the stated differ-
ences between the volumetry techniques in terms of postopera-
tive outcomes. Despite the sample size, the present authors
argue that the current work is valid as its patient population
was homogeneous and typical of patients who undergo major
hepatectomy for colorectal cancer metastases. Further, the
patient population was not contaminated by other types of
pathology, such as biliary tract cancers, as this might have
influenced the findings and affected the volumetric analysis in
the context of biliary dilation. Finally, this work was intended
to report upon the accuracy of the two most commonly used
methods of volumetry and specifically did not address out-
comes such as hepatic insufficiency because volumetric differ-
ences were felt to be an important finding in and of
themselves.
Conclusions
Measured and estimated volumetry yielded differences in the
FLR ratio of ≥5% in almost one-third of patients, potentially
affecting clinical decision making. Estimated volumetry should
thus be used cautiously and cannot be recommended for gen-
eral use.
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